7ZAX

Solution structure of thanatin-like derivative 7 in complex with K. pneumoniae LptA

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 700
2	2D 1H-13C HSQC aliphatic	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 700
3	2D 1H-13C HSQC aromatic	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 700
4	3D HNCO	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 700
5	3D HN(COCA)CB	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 700
6	3D HNCACB	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 700
7	3D 1H-13C NOESY aliphatic	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 700
8	3D 1H-13C NOESY aromatic	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 700
9	3D 1H-15N NOESY	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 700
10	3D HBHA(CO)NH	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 700
11	3D HCCH-TOCSY	300 uM [U-13C; U-15N] Lipopolysaccharide export system protein LptA, 50 mM sodium phosphate, 150 mM NaCl, 500 uM Thanatin-like derivative 4	90% H2O/10% D2O	150 mM	7.0	1 atm	298	Bruker AVANCE NEO 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE NEO	700
2	Bruker	AVANCE NEO	600

NMR Refinement
Method	Details	Software
molecular dynamics		MOE

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	3.98	Gunthert, Mumenthaler and Wuthrich
2	refinement	MOE	2020.09	Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2022
3	chemical shift assignment	CARA		Keller and Wuthrich
4	peak picking	CcpNmr Analysis		CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.